New York Life Ventures and existing investor Salesforce Ventures both contributed to a round that increased the total raised by the sales analytics software provider to $100m.
Author: Callum Cyrus
Ethos attracts GV to raise $60m
The corporate investor returned to lead a round that reportedly valued life insurance portal Ethos at $400m to $500m.
Eni helps fork over $40m for Form Energy
Grid-scale energy storage developer Form Energy has closed a series B round led by Eni Next that will fund a prototype of its lithium-sulphur battery.
Talanx takes Wellington Partners to $234m close
The venture firm has reached the final close for its latest life sciences fund, which features insurer Talanx among its LPs.
Kronos cracks $105m series A
GV contributed to a round for MIT-founded small molecule cancer drug spinout Kronos Bio, adding to $18m raised by the latter 14 months ago.
Pyxis picks up Bayer for $22m round
University of Chicago immuno-oncology spinout Pyxis Oncology has been backed by corporate investment vehicle Leaps by Bayer in its first funding round.
Trefoil triumphs with $28m
Florida State spinout Trefoil Therapeutics added funding from investors including subsidiaries of Aju Corporation and Access Biotechnology to bring its total to $33.2m.
Menlo Security decrypts $75m series D
Menlo Security has now raised approximately $150m altogether, with American Express Ventures and HSBC both returning for the latest round.
Omnidian absorbs $15m in series A round
National Grid Partners, Evergy Ventures and Avista Development all contributed to a series A round for the solar power monitoring service.
Everactive moves to $30m
Everactive has rebranded from PsiKick and secured $30m from investors including ABB Technology Ventures to boost its total funding to $63m.
Audio Analytic clicks with $12m series B
National Grid Partners invested in sound recognition technology developer Audio Analytic’s $12m series B round, which will fund product development.
SiFive siphons off series D funding
Qualcomm Ventures and existing investor Huami were among the participants in a series D round that took the specialist chipmaker’s overall funding past $130m.
OncoMyx sticks $25m series A
Boehringer Ingelheim Venture Fund co-led the oncology drug developer’s series A round with Delos Capital and Xeraya Capital.
Marubeni helps Azuei generate $26m in funding
Off-gird solar system provider Azuri secured funding in a Marubeni-led round that was also backed by IP Group, and will use it to enter new markets.